Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank82
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P82
Within normal range
vs 2Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202517.17%
2024-27.78%
202310.70%
2022-24.24%
2021-50.86%
2020-2.07%
2019-14.73%
201822.54%
201727.12%
2016-12.47%